You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Acquired hemolytic jaundiceall indications
Also known as: Acquired hemolytic jaundice
|Drug||Drug Name||Drug Description|
|DB01284||Tetracosactide||Tetracosactide (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosactide exhibits the same activity as natural ACTH with regard to all its biological activities. The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.|